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The oncogenic Merkel cell polyomavirus (MCPyV) infects humans worldwide, but little is known about the
occurrence of viruses related to MCPyV in the closest phylogenetic relatives of humans, great apes. We
analyzed samples from 30 wild chimpanzees and one captive gorilla and identified two new groups of poly-
omaviruses (PyVs). These new viruses are by far the closest relatives to MCPyV described to date, providing
the first evidence of the natural occurrence of PyVs related to MCPyV in wild great apes. Similar to MCPyV,
the prevalence of these viruses is relatively high (>30%). This, together with the fact that humans in West and
Central Africa frequently hunt and butcher primates, may point toward further MCPyV-like strains spreading
to, or already existing in, our species.
Polyomaviruses (PyVs) are known to infect a wide range of
birds and mammals (31). This includes humans, from which
eight PyVs have been identified to date, namely, BK virus
(BKV) (17), JC virus (JCV) (41), KIPyV (2), WUPyV (19),
Merkel cell polyomavirus (MCPyV) (15), human PyV 6
(HPyV6) and HPyV7 (47), and a Trichodysplasia spinulosa-
associated PyV (TSV) (52). Primary PyV infection usually oc-
curs in childhood and seems to result in lifelong persistence. In
healthy humans, PyVs have not been associated with severe
acute disease. However, PyV reactivation can cause severe
diseases in the case of immunodeficiency (23).
MCPyV has been associated to (and named after) Merkel
cell carcinoma (MCC), a rare but aggressive skin cancer (15).
Since the first report of MCC in 1972 (under the former des-
ignation “trabecular carcinoma”) (51), its incidence has been
increasing (46). MCC occurs worldwide, and its association
with MCPyV was observed in studies from several continents
(4, 18, 26, 56). Benign MCPyV infection seems to be both
common (40%) and geographically widespread (47).
MCPyV’s closest relatives known to date have been identi-
fied from two nonhuman primate species: B-lymphotropic
polyomavirus (LPV; from some African green monkeys (Chlo-
rocebus aethiops) (7) and chimpanzee polyomavirus (ChPyV)
from one chimpanzee (Pan troglodytes) (24). This raises the
possibility that MCPyV is actually part of a primate-specific
subgroup. However, little is known about the natural occur-
rence of viruses related to MCPyV in the closest relatives of
humans, the African great apes.
MATERIALS AND METHODS
Sample collection and DNA isolation. Necropsy samples (spleen, lymph nodes,
bone marrow, thymus, lung, liver, intestine, muscle, heart, pancreas, blood, urine;
n  88) were collected from 29 chimpanzees (Pan troglodytes verus) from the Taï
National Park in Coˆte d’Ivoire. The chimpanzees had died of anthrax (34),
respiratory diseases (30), or other causes (35) between 2001 and 2009. Necropsy
samples were also collected from one chimpanzee (Pan troglodytes schwein-
furthii), which was found dead in the Budongo Forest area, Uganda, and one
gorilla (Gorilla gorilla gorilla), which had been confiscated and died in the Projet
Protection des Gorilles in the Republic of Congo. For all samples originating
from Coˆte d’Ivoire, the sample collectors wore fully closed body protection suits
and masks due to a history of ebola and anthrax in these populations and to avoid
any contamination of samples with human pathogens. For the two great apes
sampled in the Republic of Congo and Uganda, the sample collectors wore at a
minimum single-use gloves and surgical masks (35). Permission for sample col-
lection from wild primates was obtained from the authorities of national parks of
each country, and tissue samples were exported with the appropriate CITES
permissions from Coˆte d’Ivoire, Uganda, the Republic of Congo, and Germany.
Importations took place according to German veterinary regulations for import
of organic materials. All samples from Coˆte d’Ivoire were preserved in liquid
nitrogen upon arrival at the research camps and were later transferred to 80°C
at the Robert Koch Institute. Other samples were stored in RNAlater (Qiagen,
Hilden, Germany). DNA was isolated using a DNeasy tissue kit (Qiagen).
PyV PCR and sequencing. (i) Generic PCR. For identification of PyVs related
to MCPyV, generic nested PCR targeting a short fragment of the VP1 gene
(approximately 260 bp) was performed using two pairs of degenerate and de-
oxyinosine-substituted primers (see Table S1 in the supplemental material). All
primers were designed to bind sites within the VP1 gene identified as being
conserved among a wide range of PyVs. They were derived from the sequence of
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MCPyV (GenBank accession no. FJ173815) in order to bias amplification toward
sequences from PyVs related to MCPyV. PCR was performed in a total volume
of 25 l with 0.4 l AmpliTaq Gold (Applied Biosystems), 20 pmol of each
primer, 200 M deoxynucleoside triphosphates, 2 mM MgCl2, and 5% dimethyl
sulfoxide. A T-Gradient thermocycler from Biometra was used with the following
cycling conditions: 95°C for 12 min and 45 cycles of 95°C for 30 s, 46°C (1st
round) or 50°C (2nd round) for 30 s, and 72°C for 2 min, followed by a 15-min
final extension step at 72°C.
(ii) Long-distance PCR. Nested specific primers were derived from the se-
quences amplified with the generic PCR (see Table S1 in the supplemental
material). They were designed tail to tail for the amplification and sequencing of
the remaining parts of the genomes. Nested long-distance PCR was performed
with the TaKaRa-Ex PCR system, according to the instructions of the manufac-
turer (Takara Bio Inc., Japan).
(iii) Diagnostic PCR. For the differential detection of chimpanzee PyVs, three
primer sets were selected. The first set (VP1-ptv1) detects P. troglodytes verus
PyV1a (PtvPyV1a) and PtvPyV1b, the second set (VP1-ptv2a/b) detects
PtvPyV2a and -2b, and the third one (VP1-ptv2c) detects PtvPyV2c (see Table S1
in the supplemental material). They were used under the PCR conditions de-
scribed above, except that AmpliTaq Gold was used at 0.2 l/25-l reaction
volume. Cycling conditions were conducted as follows: 95°C for 12 min and 45
cycles of 95°C for 30 s; 55°C (VP1-ptv1), 58°C (VP1-ptv2a/b), or 60°C (VP1-
ptv2c) for 30 s; and 72°C for 1 min, followed by a 10-min final extension step at
72°C.
(iv) Testing strategy. First, the chimpanzee samples and the gorilla sample
were tested with the generic PCR. Then, a core set of samples from which
sufficient spleen and lymph node aliquots were available (21 samples from 15
P. t. verus chimpanzees) was tested with the generic PCR as well as all three
diagnostic, PyV-specific PCRs (Table 1). A supplementary diagnostic PCR was
also used for testing of nine additional P. t. verus chimpanzees and was conducted
mainly with the VP1-ptv2c PCR only, since PtvPyV2c was the first virus discov-
ered in the course of this study (43 samples from nine individuals) (data not
shown). Additional testing of these samples with the other diagnostic PCRs was
not possible because of sample limitations.
Sequencing. All PCR products were purified by using a PCR purification kit
(Qiagen) and directly sequenced with a BigDye Terminator cycle sequencing kit
(Applied Biosystems, Warrington, Great Britain) in a 377 DNA automated
sequencer (Applied Biosystems).
Sequence analyses. Phylogenetic analyses were performed so as to determine
the positions of the newly identified strains in the Polyomaviridae family tree and
decipher the relationships between the strains belonging to the clade of MCPyV-
related PyVs. For that purpose, two alignments were generated and analyzed: (i)
an amino acid alignment of the three main coding sequences (VP1, VP2, and
large T), gathering most available polyomaviral genomes (i.e., a comprehensive
sample of the overall genomic diversity of this viral family), and (ii) a nucleotide
alignment of all distinct VP1 sequences from MCPyV-related PyVs (i.e.,
MCPyVs and the sequences depicted in this article) identified to date.
VP1, VP2, and large T amino acid sequence data set preparation and phylo-
genetic analysis. VP1, VP2, and large T sequences were recovered from the
complete genomes of polyomaviruses standing for the entire extent of the genetic
diversity of the family (i.e., 4 avian polyomaviruses and 21 mammalian polyoma-
viruses, among which are the 8 known human polyomaviruses; see Table S2 in
TABLE 1. Generic and specific PCR detection of great ape PyVs
Sample identifier Organ
PCR result
Generic
PCR
Diagnostic PCR with primer set:
VP1-ptv1 VP1-ptv2a/b VP1-ptv2c
P. t. verus 1 5740 Spleen —a — PtvPyV2a —
P. t. verus 2 6446 Lymph node — — — —
P. t. verus 3 2756 Spleen PtvPyV1b PtvPyV1b — PtvPyV2c
P. t. verus 4
2293 Lymph node — — — —
5744 Lymph node — — — PtvPyV2c
2221 Spleen — — — —
5743 Spleen — — — PtvPyV2c
P. t. verus 5 5749 Spleen — PtvPyV1a — —
P. t. verus 6
3147 Spleen — PtvPyV1a — PtvPyV2c
6444 Spleen PtvPyV1a PtvPyV1a — PtvPyV2c
P. t. verus 7 4699 Spleen — — — —
P. t. verus 8 4579 Spleen PtvPyV2b — PtvPyV2b —
P. t. verus 9
6499 Lymph node PtvPyV2c — — PtvPyV2c
6498 Spleen — — — —
P. t. verus 10 6501 Spleen PtvPyV1a PtvPyV1a PtvPyV2a —
P. t. verus 11 6506 Spleen — — — PtvPyV2c
P. t. verus 12 2757 Spleen — — — —
P. t. verus 13 6433 Lymph node PtvPyV1b — — —
P. t. verus 14
6435 Lymph node — PtvPyV1a — PtvPyV2c
5779 Spleen — — — —
P. t. verus 15 6452 Spleen — — — —
P. t. schweinfurthii 5760 Spleen PtsPyV1 NTb NT —
G. g. gorilla 5766 Spleen GggPyV1 NT NT NT
a —, PCR negative.
b NT, not tested.
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the supplemental material). The sequences from four MCPyVs were included in
all data sets so as to account for the known diversity of the species (Asian and
non-Asian MCPyV sequences were included [47]). The VP1 data set was com-
pleted with one sequence previously determined from a virus infecting a chim-
panzee, but the complete genome of that virus had otherwise not been sequenced
(24). Finally, all sequences obtained in the course of this study were added to the
data sets, irrespective of their length.
Sequences were aligned in the SeaView program (version 4) (20) using Muscle
software (13, 14) and on a web server using T-Coffee software (http://www
.tcoffee.org/; 40). Both methods produced alignments of similar quality; however,
the T-Coffee alignments were arbitrarily retained for further analyses. From each
coding sequence alignment, a protein alignment of better quality was produced
using the Gblocks server (http://molevol.cmima.csic.es/castresana/Gblocks
_server.html) (8, 50). This resulted in removing blocks of the alignments where
the hypothesis of homology was likely to be overoptimistic, a strategy that has
been proved to lead to better estimation of phylogenetic trees (50). The auto-
matically cured alignments were then manually edited in SeaView before being
reduced to unique sequences using the FaBox program (55). The process re-
sulted in three alignments: (i) VP1 with 38 unique sequences and 203 amino
acids (aa); (ii) VP2 with 28 unique sequences and 63 aa; and (iii) large T with 32
unique sequences and 407 aa. From those data sets, a concatenation which
ultimately was composed of an alignment of 673 positions, including 39 unique
sequences, was assembled. Preliminary phylogenetic analyses of individual align-
ments supported similar topologies, in particular when it comes to our clade of
interest (data not shown; individual alignments and trees are available upon
request). Therefore, the concatenated alignment was used for all following anal-
yses.
Model selection was performed on the concatenated data set using the Prot-
Test program (version 2.4) (1). Because we intended to use the software BEAST
thereafter and this software currently implements only 6 substitution matrices
(JTT, MtREV, Dayhoff, WAG, CpREV, and Blosum62), likelihoods were com-
puted for models using these substitution matrixes. All model add-ons (I, G,
or IG for rate heterogeneity modeling and F for use of empirical equilib-
rium frequencies of amino acids) were activated. Base trees for calculations were
maximum likelihood (ML) optimized (i.e., for each model, a tree was recon-
structed using PhyML) (21). Likelihoods were compared according to the Akaike
information criterion (AIC), resulting in selecting WAGIG as a model of
amino acid evolution.
Phylogenetic analyses were performed in both ML and Bayesian frameworks
under that model of amino acid evolution. ML analysis was performed on the
PhyML web server (http://www.atgc-montpellier.fr/phyml/) (21, 22). Equilibrium
frequencies, topology, and branch lengths were optimized; the starting tree was
determined using the BioNJ program; and both nearest-neighbor interchange
(NNI) and subtree pruning and regrafting (SPR) algorithms of tree search were
used (keeping the best outcome). Branch robustness was assessed by performing
nonparametric bootstrapping (500 replicates). Bayesian analyses were performed
using BEAST (version 1.5.3) (12). Besides allowing modeling of the amino acid
substitution process, BEAST also allows modeling of evolutionary rate variation
and tree shape. Analyses were run under the assumption of a relaxed, uncorre-
lated lognormal clock and two speciation models (Yule process and birth-death
model). Four independent runs totaling 8,000,000 generations were performed
under each speciation model. Trees and numerical values taken by all parameters
were sampled every 1,000 generations. The Tracer program (version 1.5) was
used to check that individual runs had reached convergence, that independent
runs converged on the same zones of parameter spaces, and that chain mixing
was satisfactory (global effective sample size values, 100) (12). Tree samples
were then gathered into a single file (after removal of a visually conservative 10%
burn-in period) using the LogCombiner program (version 1.5.3; distributed with
BEAST), and the information from approximately 7,200 trees was summarized
onto the maximum clade credibility trees using the TreeAnnotator program
(version 1.5.3; distributed with BEAST). Posterior probabilities were taken as a
measure of branch robustness. Ninety-five percent highest posterior density
(HPD) intervals for the maximum patristic distance observed for two clades of
interest were also determined from the output of BEAST analyses.
VP1 nucleotide sequence data set preparation and phylogenetic analysis. All
available MCPyV VP1 sequences as well as all sequences generated for this study
were aligned using the Muscle program, as implemented in SeaView. Given the
good quality of the alignment, only minor manual editing of the nucleotide
alignment was necessary. Reduction to unique sequences with Fabox resulted in
an alignment of 1,182 positions comprising 25 sequences.
The nucleotide substitution model to which the data were a better fit was
determined using the jModeltest program (version 0.1.1) (21, 44). Three substi-
tution schemes (Jukes and Cantor [JC], Hasegawa, Kishino, and Yano [HKY],
and global time reversible [GTR]) were examined along with rate variation (I,
G,IG) and base frequency (F) modeling. Base trees for calculations were
maximum likelihood optimized (21). According to the AIC, comparisons of
model likelihoods were more favorable to a GTRG model.
Phylogenetic analyses were performed in both maximum likelihood and Bayes-
ian frameworks under that model of nucleotide evolution. ML and Bayesian
analyses were performed as described above, with the exceptions that in Bayesian
analysis tree shape was modeled by a coalescent process (constant population
size or exponential growth) and that two experiments were run according to each
model for 4,000,000 generations total (accordingly, ca. 3,500 trees constituted the
final samples).
For both data sets, ML and Bayesian methods globally supported congruent
topologies with consistent branch supports (even though bootstrap [Bp] and
posterior probability [pp] are not directly comparable [11]), as did different
speciation and coalescent models. All .xml files (including sequence alignments)
used for Bayesian analyses are available upon request. Figures summarizing
phylogenetic analyses were drawn using the FigTree program (version 1.3.1;
http://tree.bio.ed.ac.uk/software/figtree/).
Polyomaviral species delineation. So as to put the extent of the genetic diver-
sity of the newly identified ape strains in an appropriate context, we compared it
to the known genetic diversity prevailing in four human polyomaviruses, all of
which are currently considered constituting viral species (MCPyV, BKV, JCV,
and WUPyV). For this, we took the VP1-coding sequence as a proxy of the global
genomic divergence of polyomaviruses.
In addition to the VP1 nucleotide alignment, which already encompassed the
known genetic diversity of MCPyV, three new data sets were assembled: (i) BKV
sequences spanning the entire BKV genetic diversity were taken from a study of
Krumbholz et al. (32). Representatives of the seven clades identified in this study
were included, resulting in an alignment of 1,089 positions comprising 26 se-
quences. All sequences were unique. (ii) JCV sequences representing the overall
genetic diversity of the species were taken from a study of Kitchen et al. (29).
VP1 sequences from the 92 sequences chosen by these authors to compose four
main regional groups (Asia, Europe, Japan, and the Americas) were gathered,
resulting in an alignment of 1,065 positions. The latter was then reduced to the
64 unique sequences that it comprised. (iii) WUPyV sequences were drawn from
a study of Bialasiewicz et al. (6). A total of 19 sequences representing the six
clades described in this study were gathered, constituting an alignment of 1,110
positions. From those sequences, 10 could be identified to be unique.
For each data set, pairwise distances were first computed using SeaView. As
pairwise distances are, in general, poor indicators of true evolutionary distances
(36), we also computed patristic (tree) distances. For this, all data sets were
analyzed along a common pipeline. The model of nucleotide substitution to
which the data set was a best fit was first determined using jModeltest, as detailed
above (for BKV, GTRI; for JCV, GTRIG; for WUPyV, GTRI). Then
the maximum likelihood tree was determined using PhyML (as implemented in
Seaview) under that model. Finally, patristic distances were computed from that
tree using the software Patristic (16). From both pairwise and patristic distance
matrices, maximum distances within known species were determined. Minimum
patristic distances separating newly identified strains from their closest relatives
were finally identified.
Provisional nomenclature and abbreviations of novel polyomaviruses. Names
and abbreviations for newly detected PyVs were formed from host genus and
species names and numbered arbitrarily following the results of the species
delineation, e.g., G. g. gorilla PyV1 (GggPyV1). They are listed in Table 2.
Published PyVs that were used in the analyses are listed in Table S2 in the
supplemental material.
Nucleotide sequence accession numbers. PyV sequences determined in the
course of this study have been deposited in GenBank under the following ac-
cession numbers: for PtvPyV1a, HQ385746; for PtvPyV1b, HQ326775 and
HQ385747; for PtsPyV1, HQ326774; for PtvPyV2a, HQ385748; for PtvPyV2b,
HQ326776; for PtvPyV2c, HQ385749 to HQ385751; and for GggPyV1,
HQ385752.
RESULTS
A generic nested PCR strategy aimed at amplifying a frag-
ment of the VP1 gene from MCPyV-related viral strains was
employed to test necropsy samples of 25 wild chimpanzees and
one gorilla. Fifteen chimpanzees (14/24 P. t. verus chimpanzees
and 1/1 P. t. schweinfurthii chimpanzee) and the gorilla were
PCR positive. In all cases, sequencing of PCR products con-
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firmed their infection with PyVs. For 13 chimpanzees (12 P. t.
verus chimpanzees and 1 P. t. schweinfurthii chimpanzee) and
the gorilla, preliminary BLAST analyses gave MCPyV as a first
hit (3). These MCPyV-like viruses are the focus of the present
study (information on the other chimpanzee PyVs will be pub-
lished elsewhere).
On the basis of the MCPyV-like VP1 sequences obtained
using the first protocol, nested specific primers (see Table S1 in
the supplemental material) were used for long-distance PCR
amplification and sequencing of the remaining parts of the
genomes. Seven complete genome sequences, six from chim-
panzees (P. t. verus) and one from the gorilla (Table 2), could
be determined. All genomes exhibited the typical set of PyV
open reading frames (i.e., VP1, VP2, VP3, large T, and
small T) and lacked any agnoprotein open reading frame.
Genome analysis of great ape PyVs. A high overall degree of
sequence similarity of the novel great ape PyVs to MCPyV,
including in regions otherwise less conserved among PyVs, was
observed (see Table S3 in the supplemental material). Analysis
of the noncoding control region (NCCR), the most variable
region of the PyV genome, revealed a high degree of similarity
of the great ape PyVs to MCPyV. An important motif of this
region is the DNA element GAGGC and its complement,
GCCTC. Repeats of these motifs are considered large-T-anti-
gen-binding sites (reviewed in reference 25). The highest num-
ber of these elements is found in the NCCRs of MCPyV
isolates (n  7 to 8), which are to be compared to those of
simian virus 40 (SV40), BKV, JCV (n  6), and LPV (n  4).
In MCPyV, these elements are also present in one or two
overlapping, palindromic octamers which possibly affect bind-
ing of T-antigen hexamers and initiation of DNA replication
(33). Interestingly, the novel African great ape PyVs also har-
bor eight or nine elements and three palindromic octamers
(Fig. 1).
The large T proteins exhibit a high degree of conservation of
functional domains (CR1, J, RB-binding, ori-binding, and Zn
finger domains) (43). Additionally, a region of approximately
180 amino acids extending from the J domain to the ori-bind-
ing domain rich in serine, glutamine, and threonine and pos-
sibly affecting RB-binding function (25) is also highly con-
served among the novel PyVs and MCPyVs but is absent from
LPV, BKV, JCV, and SV40 (see Fig. S1 in the supplemental
material).
In addition to its function as a virion structural protein, the
major capsid protein VP1 plays an important role during the
initial interaction of PyVs with host cells through its outfacing
loops (BC, HI) (48, 49) and contains antigenic domains (39).
Modifications in PyV VP1 loops have been shown to alter host
specificity (38). Therefore, the striking similarity between the
great ape PyVs and MCPyV in VP1, even in the highly variable
loop regions, is particularly supportive of a close relationship
between great ape PyVs and MCPyV (data not shown).
Phylogenetic analysis. Phylogenetic trees inferred from an
alignment of concatenated VP1, VP2, and large T sequences
(673 aa) comprising most known PyVs evidenced the close
relationship of wild great ape PyVs to MCPyV, which alto-
gether formed a highly supported monophyletic group (Bp and
pp values, 100 and 1, respectively) (Fig. 2). Within this group,
TABLE 2. Polyomaviruses detected in wild great apes
Specimen
no. Virus name
Sequence present
Host species Origin of host
0.21-kb VP1 5.3-kb genome
6444 PtvPyV1a x x P. t. verus Coˆte d’Ivoire
6447 PtvPyV1b x P. t. verus Coˆte d’Ivoire
6520 PtvPyV1b x x P. t. verus Coˆte d’Ivoire
5760 PtsPyV1 x P. t. schweinfurthii Uganda
6512 PtvPyV2a x x P. t. verus Coˆte d’Ivoire
4579 PtvPyV2b x P. t. verus Coˆte d’Ivoire
5924 PtvPyV2c x x P. t. verus Coˆte d’Ivoire
5927 PtvPyV2c x x P. t. verus Coˆte d’Ivoire
6413 PtvPyV2c x x P. t. verus Coˆte d’Ivoire
5766 GggPyV1 x x G. g. gorilla Republic of Congo
FIG. 1. Noncoding control region of great ape PyVs. DNA sequences of the discovered great ape PyVs and a selection of published sequences
from MCPyVs and other PyVs were compared using the ClustalW program (as implemented in the MacVector program, version 10.6) with
additional manual adjustments. Base 1 corresponds to base 5316 of the MKL-1 isolate of MCPyV (GenBank accession no. FJ173815). Conserved
regions are outlined with solid lines. The part of the alignment comprising the great ape PyVs and the MCPyVs is boxed with a dotted line.
T-antigen-binding elements (GAGGC or the complement, GCCTC) are boxed with red (GAGGC) and blue (GCCTC) lines.
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the maximum patristic distance was estimated to stand be-
tween 0.119 and 0.270 aa substitution per site (95% HPD
interval), while the maximum patristic distance to members of
the sister clade comprising primate polyomavirus sequences
was assessed as lying at between 0.539 and 0.910 aa substitution
per site (95% HPD interval) (Fig. 2). Of note, MCPyV was
firmly established as monophyletic (Bp, 91; pp, 1; Fig. 2).
Phylogenetic trees were also inferred from a nucleotide
alignment of 1,182 bp so as to refine the picture of MCPyV-like
virus relationships (all known unique MCPyV sequences were
included). This confirmed the MCPyV monophyly (Bp, 100;
pp, 1) and found support for the existence of at least two clades
of wild great ape PyVs (Fig. 3). The most basal one comprised
sequences from the gorilla and chimpanzees of the subspecies
P. t. verus only (GggPyV1 and PtvPyV2 clade). GggPyV1 ap-
peared to have diverged first from all other sequences of this
clade (Bp, 82; pp, 1; Fig. 3). All other sequences (PtvPyV1 and
PtsPyV1 clade) identified from chimpanzees (P. t. verus and P.
t. schweinfurthii) belonged to another clade which was found to
be in sistership with the MCPyV clade (Fig. 3). Within this
clade, the sequence determined from a P. t. schweinfurthii
individual was always found to be the first to diverge, though
with moderate statistical support.
Maximum VP1 patristic distances within recognized human
polyomavirus species varied from 0.016 (MCPyV) to 0.216
(BKV) nucleotide substitution per site (Table 3). All strains
belonging to the clades PtvPyV1/PtsPyV1, PtvPyV2, and Ggg-
PyV1 exhibited minimum patristic distances from the other
clades greater than 0.216 (respective minima, 0.354, 0.272, and
0.272 nucleotide substitution per site, respectively; Table 4).
Within those species, subclades were defined that gather se-
quences whose patristic distances do not outscore the maxi-
FIG. 2. Bayesian chronogram deduced from the analysis of a 673-amino-acid concatenation of VP1, VP2, and large T sequences. PyVs
identified from human hosts are in red, PyVs from chimpanzees in blue, and PyV from a gorilla in green. Ninety-five percent HPD intervals of
maximum patristic distances are indicated in parentheses for two clades (lines are drawn to the corresponding nodes). The clade formed by
MCPyVs and the newly described ape PyVs is highlighted. Statistical support for branches is given where Bp values are 70 and pp values are
0.95. Bp values are shown below the branches, and pp values are shown above the branches (pp values are those obtained from analyses
performed under the Yule model of speciation). The scale axis is in number of amino acid substitution per site. This chronogram was rooted using
a relaxed clock. A maximum likelihood analysis of the same data set concluded a similar topology, and thus, the results are not shown here. It is
noted that when only VP1 sequences were considered, ChPyV was found to be the sister taxon of the MCPyV-related PyV clade.
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mum patristic distance observed between MCPyVs (PtvPyV1a
and -b, PtsPyV1, PtvPyV2a to -c).
Prevalence of great ape PyVs. Since diverse groups of PyVs
were identified in chimpanzees, three specific PCR tests (di-
rected against PtvPyV1a/b, PtvPyV2a/b, or PtvPyV2c; see Ta-
ble S1 in the supplemental material) were used to get insight
into their respective prevalence and to determine the extent of
coinfection. All PCR products were sequenced to check for
proper clade and subclade identification. In the core sample
set (21 samples from 15 individuals), PtvPyV1 was detected in
6/15 individuals, PtvPyV2a/b was detected in 3/15 individuals,
and PtvPyV2c was detected in 6/15 individuals, corresponding
to prevalence rates of approximately 40%, 20%, and 40%,
respectively. Four of 15 individuals were coinfected (2 with
PtvPyV1a/2c, 1 with PtvPyV1b/2c, and 1 with PtvPyV1a/2a;
Table 1). Furthermore, PtvPyV2c-specific PCR was performed
FIG. 3. Bayesian chronogram deduced from the analysis of a 1,182-nucleotide VP1 alignment. PyVs identified from human hosts are in red,
PyVs from chimpanzees in blue, and PyV from a gorilla in green. Statistical support for branches is given where Bp values are 70 and pp values
are 0.95. Bp values are shown below the branches, and pp values are shown above the branches (pp values are those obtained from analyses
performed under the constant-population-size model of coalescence). The scale axis is in number of nucleotide substitution per site. This
chronogram was rooted using a relaxed clock (midpoint rooting of the maximum likelihood tree identified the same root). A maximum likelihood
analysis of the same data set concluded a similar topology, and thus, the results are not shown here.
TABLE 3. Maximum pair-wise and patristic distances observed in four human polyomaviral species
Virus Maximum pairwisedistance
Maximum patristic
distance Most distantly related sequences (patristic distances)
MCPyV 0.016 0.016 MCC350 and 10b (Asian clade), GenBank accession nos. NC_010277 and HM011540
WUV 0.023 0.054 O342 (IIIb) and FZ18 (Ia), GenBank accession nos. GU296362 and FJ890981
JCV 0.036 0.141 Italy03 and Peru01, GenBank accession nos. AB074582 and AB081023
BKV 0.075 0.216 KOM7 (18) and CAP-m13 (28), GenBank accession nos. AB211388 and AY682230
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on nine additional individuals, among which three were found
to be positive (not listed). Together with the data from the core
set (Table 1), PtvPyV2c was thus detected in 9/24 individuals
(38%).
DISCUSSION
Here PyVs infecting wild African great apes were discovered
and shown to be closely related to human MCPyV using ge-
nome analysis (Fig. 1; see Fig. S1 and Table S3 in the supple-
mental material) and phylogenetic analysis (Fig. 2 and 3).
These findings are particularly interesting since they convinc-
ingly demonstrate that MCPyV stems from a (so far) primate-
specific and even ape-specific group of PyVs.
Though this might at first be seen as an argument in favor of
the cospeciation hypothesis (42), two diverging interpretations
of our phylogenetic trees can be made that end up with con-
trasting conclusions about the processes at play along MCPyV-
related PyV evolution. If three distinct MCPyV-related PyVs
whose present descendants would be MCPyV, PtvPyV2/GggPyV1,
and Ptv/PtsPyV1, respectively, are assumed to have been in-
fecting the last common ancestor of African great apes, then
the fact that along two of the corresponding evolutionary lin-
eages (those leading to PtvPyV2/GggPyV1 and Ptv/PtsPyV1)
species-specific patterns are not contradicted would indeed be
consistent with the codivergence hypothesis. On the contrary,
if the last common ancestor of all African great apes is as-
sumed to have been infected with only one MCPyV-related
PyV (the last common ancestor of all MCPyV-related PyVs),
then strict codivergence is an unsatisfactory explanation for the
observed phylogenetic pattern (i.e., a bad overlap of viral and
host phylogenies) and some degree of host switching has to be
assumed as well. Our data do not allow favoring one hypothesis
over the other. Therefore, the question of the modalities of
evolution of PyVs related to MCPyV remains largely open.
The finding of new viral strains that cannot be identified
directly as belonging to a recognized species raises the ques-
tion of their taxonomic status (i.e., are they likely to represent
new viral species?). Viral species delineation is often contro-
versial (54), including among the Polyomaviridae (31). In par-
ticular, when only sequences are available, it is impossible to
define any objective threshold beyond which genetic diver-
gence undoubtedly reflects the existence of separate viral spe-
cies (54). Here we find that three entities—two clades (Ptv/
PtsPyV1 and PtvPyV2) and a single sequence (GggPyV1)—
present minimum patristic distances to their closest outgroup
relatives greater than the maximum patristic distance observed
within BKV, the human polyomavirus with the highest degree
of genetic diversity known thus far. On the basis of this obser-
vation, we propose to provisionally consider those three enti-
ties as separate viral species (or at least as separate taxa of the
same rank as BKV). This should obviously not be taken as
implying that they have different biological properties, whose
characterization will be required to truly install those groups of
viruses as valid viral species (45, 54).
This being said, it is striking that PyVs related to MCPyV
circulating in chimpanzees are, from a genetic standpoint,
much more diverse than the human MCPyVs described so far
(and are actually even more diverse than any human PyV), all
the more so since nearly the entire extent of this diversity could
be found in a single P. t. verus chimpanzee community of the
Taï National Park, Coˆte d’Ivoire. This could be interpreted as
indicating that West Africa (and possibly Central Africa) is a
hot spot of MCPyV-related PyV diversity. These data may
point toward a higher degree of genetic diversity of MCPyV in
humans worldwide and specifically in West and Central Africa,
where conclusive studies with human populations are missing
(47).
Though our analyses do not provide direct evidence that
MCPyV was transmitted from apes to humans, the presence of
PyVs related to MCPyV in wild great apes is also significant
with respect to human health. SV40 and LPyV are much more
distantly related to MCPyV than PtvPyV1, PtvPyV2, or Ggg-
PyV1. However, they seem to infect humans, as suggested by
their identification in human samples (7, 10, 27, 37). If the
assumption is made that the closer that two species are the
higher that the likelihood of successful transmission of their
respective pathogens is (the preferential host switching hy-
pothesis) (9), then transmission of great ape PyVs to sympatric
humans must be considered. Besides, the practical determi-
nants of a successful transmission to human populations are
already in place. First, according to our data set, PtvPyV is
infecting chimpanzees (including coinfections with various
strains) at a high prevalence rate, at least in the Taï Forest,
Coˆte d’Ivoire. Second, nonhuman primates (including chim-
panzees and gorillas) still represent an important proportion of
the bush meat consumed in West and Central Africa (ca. 12%)
(5). Hunting and butchering of bush meat have been shown to
provide the major routes of pathogen transmission to humans
(e.g., human immunodeficiency viruses) (28, 53). This could
well apply to PyVs related to MCPyV.
The wide variety of MCPyV-related viruses in African great
apes presented here calls for larger studies to unravel the
diversity of PyVs related to MCPyV currently circulating in
nonhuman primates of West and Central Africa (and more
particularly in apes) as well as in local human populations. It is
reasonable to assume that such studies will reveal unprece-
dented levels of PyV diversity, which will provide a sound basis
TABLE 4. Minimum patristic distance involving the new
great ape PyVs
PyV
Minimum
patristic
distance
Closest relative(s)
(patristic distance)
Minimum patristic
distance to other
groups of
sequences
6444_PtvPyV1a 0.043a 6520_PtvPyV1b 0.354b
6447_PtvPyV1b 0.010 6520_PtvPyV1b
6520_PtvPyV1b 0.010 6447_PtvPyV1b
5760_PtsPyV1c 0.078 6520_PtvPyV1b
6512_PtvPyV2a 0.028 4579_PtvPyV2b 0.272
4579_PtvPyV2b 0.028 6512_PtvPyV2a
5924_PtvPyV2c 0.002 5927_PtvPyV2c
5927_PtvPyV2c 0.002 5924_PtvPyV2c
6413_PtvPyV2c 0.006 5927_PtvPyV2c
5766_GggPyV1 0.272 6512_PtvPyV2a 0.272
a Values outscoring MCPyV maximum patristic distance are italicized.
b Values outscoring the maximum patristic distance observed in a human PyV
(i.e., 0.216 substitution per site for BKV) are in boldface.
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for a better assessment of both PyV natural history and the risk
that nonhuman primate PyVs really pose.
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